Getting Melanotan I Dosing Right: A Step-by-Step Walkthrough

Melanotan I at a glance:

• Drug class: Cosmetic peptide
• Route: topical for most; injectable melanotans are unlicensed
• Typical frequency: daily topical application typical
• Half-life: topical residence time varies

Dosing Melanotan I correctly isn't complicated, but the details matter. The standard schedule is daily topical application typical via topical for most; injectable melanotans are unlicensed, and the key decisions happen during titration.

Standard Dosing Schedule for Melanotan I

Cosmetic peptides in skincare are regulated as cosmetics, not drugs. Injectable melanotans are not FDA-approved.

The typical schedule for Melanotan I is daily topical application typical via topical for most; injectable melanotans are unlicensed. Half-life of topical residence time varies explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for Melanotan I holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Melanotan I is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (topical residence time varies) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in Melanotan I side effects and the cost angle of dose escalation in Melanotan I cost.

What the Trials Used

Published clinical data on this compound is limited. Most reported dosing comes from observational or non-clinical sources.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Melanotan I: the standard contraindications for this drug class apply.

Bottom Line

The single biggest dosing mistake we see with Melanotan I is impatience — skipping titration steps to get to the goal dose faster. It almost always backfires.

Frequently Asked Questions

Related Reading

• What Is Melanotan I? Everything You Should Know Before Starting
• What Nobody Tells You About Melanotan I Side Effects
• Melanotan I Results: What the Real Numbers Show in 2026
• How Much Does Melanotan I Really Cost? The Honest Breakdown
• Melanotan II Explained: How It Works and Who It's For
• Melanotan II Side Effects in 2026: Real Reports, Real Solutions

Sources

• Habbema L et al. Risks of Unregulated Use of Alpha-Melanocyte-Stimulating Hormone Analogues. Br J Dermatol 2017;176:633.
• Pickart L. The Human Tri-Peptide GHK and Tissue Remodeling. J Biomater Sci Polym Ed 2008;19:969.

This page is informational only and is not medical advice. Always follow your prescribing clinician's dosing instructions.